MMedication Read More Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concernsJanuary 15, 2026 Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…
HHealth Read More Flu Patients Struggle to Find Tamiflu as Virus Surges Across USJanuary 8, 2026 The antiviral treatment Tamiflu is in short supply in parts of the US, as patients and pharmacists battle…
HHealth care Read More BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®January 8, 2026 BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
MMedication Read More US FDA declines to approve Corcept’s drug for rare hormonal disorderJanuary 2, 2026 By Sneha S K and Sahil Pandey Dec 31 (Reuters) – The U.S. Food and Drug Administration has…
MMedication Read More Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with HypercortisolismJanuary 1, 2026 REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
MMedication Read More Vanda Jumps 21% After FDA Approves Motion Sickness TherapyDecember 31, 2025 This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
HHealth Read More Inside the FDA’s vaccine uproarDecember 19, 2025 Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused…
MMedication Read More FDA OKs libido-boosting pill for older women who have gone through menopauseDecember 15, 2025 WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…
HHealth Read More Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseasDecember 14, 2025 If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late…
BBusiness Read More Appointment of controversial FDA official rocking agency like “an atom bomb,” scientists there sayDecember 7, 2025 The Trump administration’s elevation of a vaccine skeptic to lead a high-profile office within the Food and Drug…